BHLHE40 and pancreatic neoplasm: Single-cell sequencing data obtained by Wang et al., 2023 [31], revealed that BHLHE40-driven pro-tumour neutrophils exhibit hyperactivated glycolysis in the pancreatic tumour microenvironment, promoting adverse outcomes in PDAC.